Varicella vaccine: genesis, efficacy, and attenuation.
Arvin
A M
AM
Department of Pediatrics, Stanford University School of Medicine, Stanford, California 94305, USA. aarvin@stanford.edu
D000818:Animals; D019433:Chickenpox Vaccine / Q000235:genetics / Q000276:immunology*; D002986:Clinical Trials as Topic; D016384:Consensus Sequence; D016679:Genome, Viral; D006566:Herpesviridae Infections / Q000517:prevention & control; D014645:Herpesvirus 3, Human / Q000235:genetics / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular; D007121:Immunocompetence; D016366:Open Reading Frames; D017421:Sequence Analysis; D014611:Vaccination; D014613:Vaccines, Attenuated / Q000235:genetics / Q000276:immunology
D019433:Chickenpox Vaccine; D014613:Vaccines, Attenuated